Search results
Targeting leukemia's survival route: A novel approach to overcoming leukemia recurrence
Medical Xpress· 19 hours agoResearchers from Karolinska Institutet have, in collaboration with the University of Eastern Finland and Lund University, published a study in Genome Biology demonstrating that targeting < ...
Cancer researchers discover optimal cancer-killing T cells
Medical Xpress· 7 days agoT cell-based immunotherapy has tremendous value to fight, and often eliminate, cancer. The strategy activates a patient's immune system and engineers a ...
HPV vaccine prevents cancer in males as well as females, researchers say
MedicalNewsToday via AOL· 20 hours agoA new analysis reveals that HPV vaccinations may reduce the risk of HPV-related cancers by as much...
Response To FDA Black Box Warning
BioresearchOnline· 20 hours agoThe FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies, which involve genetically engineering T...
22 high-protein, low-carb foods
TODAY via Yahoo News· 6 days agoA 3-ounce serving has 22 grams of protein. Pork also contains vitamin B12 and B6, iron and zinc. It’s also high in selenium, which contains antioxidants....
... Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
The Pendulum· 2 days ago...committed to developing novel medicines for the treatment of cancer and immunological diseases, presented the latest data from the inaugural global pivotal study WU-KONG1 Part B (WU-KONG1B) of sunvozertinib in relapsed or refractory non-small cell lung cancer (NSCLC) with epidermal growth factor...
AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative...
WROC Rochester· 7 days agoNew safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of ABBV-400, a next-generation ...
Chinese cell therapy may treat asthma long term with a single jab: study
South China Morning Post· 2 days agoIn their latest study, Peng’s team developed a new way to target this group of cytokines...
Affimed's AFM24 With Atezolizumab For EGFR Wild-Type NSCLC Gets FDA Fast Track Status; Stock Up
RTT News· 6 days agoAffimed N.V. (AFMD), a clinical-stage immuno-oncology company, Wednesday announced that it has received Fast Track Designation from the U.S. Food and Drug Administration for combination therapy ...
Gene variants foretell the biology of future breast cancers, study finds
Medical Xpress· 5 days ago"Apart from a few highly penetrant genes that confer significant cancer risk, the role of heredity factors remains poorly understood, and most malignancies are assumed to ...
